VANDERBILT UNIVERSITY MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vumc.org
SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
Phase 4
Recruiting
- Conditions
- Vascular DiseasesBrain DiseaseVascular InflammationEndothelial DysfunctionKidney Injury
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 170
- Registration Number
- NCT05812755
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT05774717
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve
Not Applicable
- Conditions
- Head and Neck CancerObstructive Sleep Apnea
- Interventions
- Device: Nerve stimulation using nerve stimulation device and sterile wire electrode.
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT05754216
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT05746546
- Locations
- 🇺🇸
Vanderbilt Psychiatric Hospital, Nashville, Tennessee, United States
Depressed Mood Improvement Through Nicotine Dosing 3
Phase 2
Recruiting
- Conditions
- Depressive Disorder
- Interventions
- Drug: Transdermal Placebo Patch
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT05746273
- Locations
- 🇺🇸
Vanderbilt Psychiatric Hosptial, Nashville, Tennessee, United States
3D Specimen Maps for RT Planning
Recruiting
- Conditions
- Head and Neck CancerHead and Neck Squamous Cell CarcinomaRadiation Therapy
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 13
- Registration Number
- NCT05743569
- Locations
- 🇺🇸
Vanderbilt Medical Center, Nashville, Tennessee, United States
The Clinical Impact of Diet on Medical Conditions Treated Within Bundled Payment Models: a Pilot Study
Not Applicable
Withdrawn
- Conditions
- Osteoarthritis, KneeHypertensionType 2 DiabetesObesity
- Interventions
- Other: Low-energy diet
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT05735873
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
Not Applicable
Recruiting
- Conditions
- End Stage Renal Disease on Dialysis
- Interventions
- Behavioral: Motivational interviewing
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 176
- Registration Number
- NCT05735743
- Locations
- 🇺🇸
DaVita Philadelphia PMC Dialysis, Philadelphia, Pennsylvania, United States
🇺🇸DaVita University City Dialysis, Philadelphia, Pennsylvania, United States
🇺🇸Dialysis Clinic, Inc., Nashville, Tennessee, United States
Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Vanderbilt University Medical Center
- Registration Number
- NCT05724849
Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)
Not Applicable
Completed
- Conditions
- Peripheral Pulmonary Lesions
- Interventions
- Device: Ion™ Endoluminal System (SSCB bronchoscopy)Device: ILLUMISITE™ Platform (EMN bronchoscopy)
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 447
- Registration Number
- NCT05705544
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath